9 METERS BIOPHARMA, INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
9 Meters Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to 2022.
  • 9 Meters Biopharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was -$12.3M.
  • 9 Meters Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $19.9M, a 51.5% decline from 2021.
  • 9 Meters Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $41.1M, a 26.5% decline from 2020.
  • 9 Meters Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $55.9M, a 232% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $19.9M -$21.1M -51.5% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-28
2021 $41.1M -$14.8M -26.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 $55.9M +$39M +232% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-23
2019 $16.8M -$3.71M -18.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-22
2018 $20.6M +$15.4M +301% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-20
2017 $5.13M -$4.63M -47.4% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 $9.76M Jan 1, 2016 Dec 31, 2016 10-K 2018-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.